Replay available

Neuropace, Inc. (NPCE) Q2 2025 Earnings Call

Neuropace, Inc. (NASDAQ: NPCE) Q2 2025 earnings conference call, held 2025-08-12. Replay captured from the company's public earnings webcast.

Tue, August 12, 2025 at 4:30 PMendedReplay
Neuropace, Inc. (NPCE) Q2 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Scott Schaefer

Head of Investor Relations, NeuroPace, Inc.

Joel Becker

Chief Executive Officer

Patrick Williams

Chief Financial Officer

Rohan Patel

Analyst, J.P. Morgan

Priya Sajdeva

Analyst, UBS

Vic Chopra

Analyst, Wells Fargo

Frank Tuckinen

Analyst, Lake Street Capital Markets

Ross Austin

Analyst, Cantor Fitzgerald

Yi Chen

Analyst, H.C. Wainwright & Co.

Replay transcript excerpt

Ladies and gentlemen, greetings and welcome to the NeuroPace Inc. Second Quarter 2025 Earnings Call. At this time, all participants are in the listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star and zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Scott Schaefer, Head of Investor Relations at NeuroPace, Inc. Please go ahead. Good afternoon. Thank you for joining us for NeuroPace's second quarter 2025 Financial and Operating Results Conference Call. On today's call, we will hear from Joel Becker, Chief Executive Officer, and Patrick Williams, Chief Financial Officer. Earlier today, Neuropace released financial results for the second quarter ended June 30, 2025. A copy of the press release is available on the company's website at neuropace.com. Before we begin, I would like to remind you that throughout this call, we will make statements that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements. All forward-looking statements, including those around narrow-paces projections, business opportunities, commercial expansion, market conditions, clinical trials, and those relating to our operating trends and future financial performance, expense management, Estimates of market opportunity and forecast of market and revenue growth are based on current estimates and various assumptions. Thes...

More from Neuropace, Inc.